RA Capital Management Overview

  • Investor Type

  • Hedge Fund

  • Status

  • Active

  • Professionals

  • 43

Professionals
  • Investments

  • 385

  • Portfolio

  • 139

  • Exits

  • 180

Exits

RA Capital Management General Information

Description

Founded in 2001, RA Capital Management is a hedge fund manager based in Boston, Massachusetts. The firm employs a long/short and sector-oriented hedge fund strategy. Th firm also invests in early-stage companies. The firm prefers to invest in healthcare and life science companies developing drugs, medical devices, services & research tools, and diagnostics sectors based in the United States and Europe.

Contact Information

Website
www.racap.com
Year Founded
2001
Investor Status
Actively Seeking New Investments
Trade Association
New England Venture Capital Association (NEVCA)
Primary Investor Type
Hedge Fund
Other Investor Types
Growth/Expansion
Venture Capital
Primary Office
  • 200 Berkeley Street
  • 18th Floor
  • Boston, MA 02116
  • United States
+1 (617) 000-0000

RA Capital Management Investments & Acquisitions (385)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Pluton Biosciences 02-Jun-2023 Later Stage VC 000.00 Biotechnology Generating Revenue 0000000 000000000 00
000000 00000000000 25-May-2023 00000 00000 00000 Drug Discovery Clinical Trials - General
000000000 000 16-May-2023 00000 00000 00000 Drug Discovery Clinical Trials - Phase 2
0000000000 0000000 27-Apr-2023 00000 00000 0000 Biotechnology Pre-Clinical Trials 0000 000000 00.0
0000000 (000000000 17-Apr-2023 00000 00000 000.00 Clinics/Outpatient Services Generating Revenue 000000 0000000000
0000000 0000000000 13-Apr-2023 00000 00000 00000 Drug Discovery Clinical Trials - Phase 1
0000000 04-Apr-2023 00000 00000 000.00 Drug Discovery Pre-Clinical Trials 0000 00000 00.0
00000000 000 04-Apr-2023 00000 00000 0000 Drug Discovery Generating Revenue 00000000 0000000 00.0
Orchard Therapeutics 10-Mar-2023 PIPE 00000 Drug Discovery Generating Revenue
Unicycive 08-Mar-2023 PIPE 00000 Drug Discovery Generating Revenue
You’re viewing 10 of 385 investments and acquisitions. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RA Capital Management Exits (180)

Company Name Exit Date Exit Type Exit Size
Mineralys 10-Feb-2023 IPO 00000
0000000000 12-Dec-2022 000000000000000000
0000000 0000000000 15-Nov-2022 000 000.00
000 00000000000000 08-Nov-2022 0000000 000000 00000
0000000 27-Sep-2022 000000000000000000 00000
00000 000000000000 01-Sep-2022 000000000000000000 00.00
00000 30-Jun-2022 000000 0000000000 000.00
00000000 000000000 16-Jun-2022 000000000 00000000
PepGen 06-May-2022 IPO 00000
HilleVax 29-Apr-2022 IPO 00000
You’re viewing 10 of 180 exits. Get the full list »

RA Capital Management Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

RA Capital Management Team (101)

Name Title Deals Funds Boards Office
Gregg Rubin Chief Credit Officer & President Boston, MA
Reza Halse Ph.D President 0 0 0 Boston, MA
Michael Saulnier Chief Financial Officer Boston, MA
Andrew Levin Ph.D Partner & Managing Director 00 0 00 Boston, MA
Pieter Boelhouwer JD Partner & Managing Director, Strategy & Operations 0 Boston, MA
You’re viewing 5 of 101 team members. Get the full list »

RA Capital Management Co-Investors (573)

Name With Exits Lead Partner Series Industry
Janus Henderson Investors 32 0 0 Series chart Industry bar
Logos Capital 00 0 00 Series chart Industry bar
OrbiMed 00 0 00 Series chart Industry bar
Cormorant Asset Management 00 0 0 Series chart Industry bar
Perceptive Advisors 00 0 00 Series chart Industry bar
You’re viewing 5 of 573 co-investors. Get the full list »